NCT00162058View on ClinicalTrials.gov

A Phase II Study of DMP 115 to Assess Focal Liver Lesions

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
Liver Disease
Interventions
DRUG

Peflutren Lipid Microsphere Injectable Suspension

Trial Locations (1)

Unknown

Local Institution, Glasgow

Sponsors
All Listed Sponsors
lead

Lantheus Medical Imaging

INDUSTRY